Back

SGLT2 inhibitors: is the benefit related to renal outcomes?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors and cardiovascular outcomes Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Antonio Ceriello

IRCCS - MultiMedica, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors and atherosclerosis-related outcomes: the good and the bad
Professor A. Norhammar (Stockholm, SE)
Slides Video
Presentation thumbnail
SGLT2 inhibitors and heart failure: expensive diuretics or added value?
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
Panel discussion: how should cardiologists use SGLT2 inhibitors in clinical practice?
Video

Access the full session

Session thumbnail
SGLT2 inhibitors and cardiovascular outcomes

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Congress Presentation
Diabetes as a major comorbidity in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources